HHS Moves to Challenge Ruling on Vaccine Policy Changes
The U.S. Department of Health and Human Services (HHS) is appealing a ruling that impacts vaccine policy, following a lawsuit by the American Association of Pediatrics.
Editorial Staff Apr 30
Medicine
Latest Medicine stories from Life.
Innovative Biaryl Synthesis Method Developed by Tokyo Researchers
A new method for synthesizing polyfunctionalized biaryls without the use of transition-metal catalysts has been introduced by researchers at the Institute of Science Tokyo.
Editorial Staff Apr 29
Medical Students Push for Nutrition Focus in Education
A group of medical students emphasizes the importance of integrating nutrition into medical training, advocating for a shift toward preventive health education.
Editorial Staff Apr 29
The Appeal of Alternative Medicine Over Conventional Health Care
While modern medicine aims to improve health, it often overlooks the importance of patient comfort and emotional well-being, leading many to seek alternative options.
Editorial Staff Apr 29
Transforming Drug Development: The Promise of Real-Time Clinical Trials
The FDA commissioner highlights how real-time clinical trials could change the landscape of drug development by providing regulators with immediate data insights.
Editorial Staff Apr 28
Concerns Mount Over Trump's Drug Pricing Policy and Purdue Pharma's Legal Troubles
Industry leaders express significant worries regarding the implications of Trump's drug pricing plan, while Purdue Pharma's sentencing underscores persistent challenges in the pharmaceutical sector.
Editorial Staff Apr 28
Concerns Grow Over New U.S. Hepatitis B Vaccine Policy for Newborns
A recent recommendation to limit hepatitis B vaccinations at birth to only those infants deemed at risk raises alarms about potential increases in infections among newborns.
Editorial Staff Apr 27
Erasca's Experimental Cancer Drug Shows Encouraging Early Trial Results
Erasca has reported that its experimental treatment for pancreatic and lung cancers has delivered results that exceed initial expectations in early trials.
Editorial Staff Apr 27
Trump Administration Issues Warning on Federal Funding for Fentanyl Test Strips
The Trump administration has expressed concerns regarding the use of federal funds for fentanyl test strips, indicating a shift away from harm reduction strategies.
Editorial Staff Apr 27
Astellas Resumes XLMTM Gene Therapy Trials Following Previous Fatalities
Astellas is moving forward with its XLMTM gene therapy trials despite earlier reports of deaths. Meanwhile, Veradermics celebrates success in its hair loss pill trial, and the FDA accelerates reviews for psychedelics.
Editorial Staff Apr 27
Exploring the Narratives Behind Transformative Medications
In the podcast "Drug Story," host Thomas Goetz discusses how society often misuses medications like Ambien and Ozempic, highlighting a disconnect between drug use and bodily needs.
Editorial Staff Apr 25
U.S. Military Strike Claims Six Lives in Eastern Pacific Drug Operation
A recent U.S. military strike on a suspected drug boat in the Eastern Pacific resulted in six fatalities, contributing to a rising death toll linked to anti-drug operations.
Editorial Staff Apr 25
Expansion of International Childhood Vaccine Initiative Marks a New Era in Health Policy
Today's health news highlights the growth of an international childhood vaccine campaign alongside a shift in GOP drug policy, signaling significant changes in public health efforts.
Editorial Staff Apr 24
Trump Announces Completion of Initial Drug Pricing Agreements
President Trump has finalized a series of drug pricing agreements, with the last deal involving Regeneron, marking the conclusion of 17 agreements pursued by the White House.
Editorial Staff Apr 24
Sanofi's Multiple Sclerosis Drug Approved in Europe After FDA Rejection
A multiple sclerosis treatment from Sanofi has received a positive review in Europe, marking a notable shift after its rejection by the FDA last year.
Editorial Staff Apr 24
Embarking on a Medical Career at 72: A Journey of Resilience
Dawn Zuidegeest-Craft shares her experience of starting medical school at 69 and now preparing for residency at 72, highlighting the challenges and lessons learned.
Editorial Staff Apr 24
Trump Administration's Shift on Drug Policy: Embracing Psychedelics and Cannabis
In a notable shift from previous GOP stances, the Trump administration is now supporting research into psychedelics and reconsidering marijuana's legal status.
Editorial Staff Apr 23
Trump's Reclassification of Medical Marijuana Marks a Significant Policy Change
In a notable policy shift, President Trump has reclassified state-licensed medical marijuana as a less-dangerous drug, a change that advocates have long pursued.
Editorial Staff Apr 23
Colorado and Virginia Legislatures Push Back Against Drug Affordability Board Restrictions
Legislators in Colorado and Virginia are opposing efforts to limit the powers of prescription drug affordability boards, highlighting a significant debate over drug pricing strategies.
Editorial Staff Apr 23
New Medicare Pathway Proposed for Breakthrough Medical Devices by CMS and FDA
Federal regulators are set to unveil a new Medicare coverage pathway aimed at accelerating access to FDA-designated breakthrough medical devices, enhancing treatment options for patients.
Editorial Staff Apr 23